These final results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the notion of targeting ACKR3 as a singular solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. This plant-based mostly component https://raymondc062vme8.bligblogging.com/profile